SFI
GH icon

Susquehanna Fundamental Investments’s Guardant Health GH Stock Holding History

Susquehanna Fundamental Investments’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,775
Closed -$590K – 559
2025
Q4 		$590K Hold
5,775
– – 0.02% 409
2025
Q3 		$361K Sell
5,775
-82,642
-93% -$4.5M 0.01% 460
2025
Q2 		$4.6M Hold
88,417
– – 0.12% 215
2025
Q1 		$3.77M Buy
88,417
+3,150
+4% +$136K 0.05% 382
2024
Q4 		$2.6M Buy
+85,267
New +$2.4M 0.04% 459

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna Fundamental Investments's GH Position: Q1 2026 in Review

Susquehanna Fundamental Investments sold out of Guardant Health (GH) in Q1 2026, closing a stake of 5,775 shares — an estimated $590K sold.

Susquehanna Fundamental Investments first reported a position in GH in Q4 2024 and held it in 5 quarters. The position peaked at $4.6M in Q2 2025. 482 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Susquehanna Fundamental Investments reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 5,775 Guardant Health shares in Q1 2026, an estimated $590K.
  • Susquehanna Fundamental Investments first reported a position in Guardant Health in Q4 2024 and held it in 5 quarters.
  • Susquehanna Fundamental Investments's Guardant Health position peaked at $4.6M in Q2 2025.
  • 482 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2026, filed 15 May 2026.